MENU
NEUP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neuphoria Therapeutics (NEUP) Ownership - Who owns Neuphoria Therapeutics?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.11B
P/E Ratio
N/A
Total Cash
12.08M
Projected Growth
N/A
Total Debt
254.01K
Revenue
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NEUP
Capitalization
11.1B
P/E Ratio
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
12.1M
Total Cash/Share
0.00
Total Debt
254K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
17.1M
P/B Ratio
666.67
Cash Flow
N/A
Earnings
-0.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
3.30
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-15.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-47.23
Shares Held By Institutions
858K
Shares Outstanding - Current
3.52B
Total Liabilities
5.85M
Total Volume MTD
N/A
Value
-1
Gain YTD
-7.872
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information